Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (941)	7/12/1997 5:01:00 AM
From: JOHN W.	of 6136

Dave? "defending the stock from bogus attacks from shorts"...... "I find it easier to attempt to be forthright with my post" ???? After therapy, I suggest increased attempts to be forthright and stop conducting bogus attacks on AGPH. If you are trying to suggest AGPH is going to run out of cash prior to bringing the pipeline to market, don't insult our intelligence. AGPH will have at a min of 2 drugs on the market before VX-478 gets approved (hopefully 1999) and then has to compete with nelf. And don't forget your comments on the vulnerability of PIs to new treatments. Viracept is a second generation PI which is already on the market. BTW, I appreciate your humor and jokes. I think everything you write is funny. Best wishes, John.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next